サマリー

セフェピムは、第4世代のセファロスポリンです。その抗菌スペクトルはさらに拡大されており、腸内細菌、緑膿菌などの非醗酵菌、ヘモフィルス、ブドウ球菌など、さまざまなグラム陽性菌および陰性菌に対して強い抗菌力を有しています。感受性の高い細菌による各種感染症、主に黄色ブドウ球菌、大腸菌、緑膿菌などの副反応による呼吸器感染症に使用されます。

市場分析と洞察。世界および米国のCefepime市場
当レポートでは、世界および米国のCefepime市場に焦点を当てています。
2020年のCefepimeの世界市場規模はXX百万米ドルで、2021-2027年の間にXX％のCAGRで、2027年末までにXX百万米ドルに達すると予想されています。米国では、Cefepimeの市場規模は、2020年のXX百万米ドルから2027年にはXX百万米ドルまで、予測期間中にXX％のCAGRで成長すると予想されています。

世界のCefepimeの範囲と市場規模
Cefepime市場は、地域（国）別、プレイヤー別、タイプ別、アプリケーション別に分類されています。世界のCefepime市場に参加するプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年までの地域（国）別、タイプ別、アプリケーション別の収益と予測に焦点を当てています。
米国市場では、2016-2027年のCefepimeの市場規模を、プレイヤー別、タイプ別、アプリケーション別に調査しています。主要なプレイヤーには、米国で重要な役割を果たす世界的なプレイヤーや地域のプレイヤーが含まれます。

タイプ別セグメント
筋肉内注射
静脈内ドラッグデリバリー

アプリケーション別
下部呼吸器系感染症
泌尿器系感染症
皮膚・軟部組織感染症
腹腔内感染症
婦人科領域の感染症
敗血症
好中球性発熱

地域別
北アメリカ
U.S.
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジアパシフィック
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中近東・アフリカ
トルコ
サウジアラビア
UAE

会社別
バクスター
Apotex
ビー・ブラウン・メディカル
ファイザー
ペリゴ
フレゼニウス・カビ
サンドス（ノバルティス）社
ピラマル クリティカルケア
Meitheal Pharmaceuticals
BMS
Qilu製薬
シノファーム
上海新豊製薬
河北華敏製薬
南京海健製薬
山東洛神製薬グループ
広州白雲山天心製薬
岳康製薬グループ
成都北投製薬
江蘇省Hengrui製薬
海南スター製薬
海南海鈴製薬(株)
深圳新里泰製薬
深圳麗澤医薬有限公司
蘇州東瑞製薬

ページTOPに戻る

目次

1 Study Coverage
1.1 Cefepime Product Introduction
1.2 Market by Type
1.2.1 Global Cefepime Market Size Growth Rate by Type
1.2.2 Intramuscular Injection
1.2.3 Intravenous Drug Delivery
1.3 Market by Application
1.3.1 Global Cefepime Market Size Growth Rate by Application
1.3.2 Lower Respiratory Tract Infection
1.3.3 Urinary Tract Infection
1.3.4 Skin And Soft Tissue Infections
1.3.5 Abdominal Cavity Infection
1.3.6 Gynecologic Infection
1.3.7 Sepsis
1.3.8 Neutrophilic Fever
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Cefepime Market Size, Estimates and Forecasts
2.1.1 Global Cefepime Revenue 2016-2027
2.1.2 Global Cefepime Sales 2016-2027
2.2 Global Cefepime, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Cefepime Historical Market Size by Region (2016-2021)
2.3.1 Global Cefepime Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Cefepime Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Cefepime Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Cefepime Sales Forecast by Region (2022-2027)
2.4.2 Global Cefepime Revenue Forecast by Region (2022-2027)

3 Global Cefepime Competitor Landscape by Players
3.1 Global Top Cefepime Manufacturers by Sales
3.1.1 Global Cefepime Sales by Manufacturer (2016-2021)
3.1.2 Global Cefepime Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Cefepime Manufacturers by Revenue
3.2.1 Key Cefepime Manufacturers Covered: Ranking by Revenue
3.2.2 Global Cefepime Revenue by Manufacturers (2016-2021)
3.2.3 Global Cefepime Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Cefepime Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Cefepime Revenue in 2020
3.2.6 Global Cefepime Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Cefepime Price by Manufacturers
3.4 Global Cefepime Manufacturing Base Distribution, Product Types
3.4.1 Cefepime Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Cefepime Product Type
3.4.3 Date of International Manufacturers Enter into Cefepime Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Cefepime Market Size by Type (2016-2021)
4.1.1 Global Cefepime Sales by Type (2016-2021)
4.1.2 Global Cefepime Revenue by Type (2016-2021)
4.1.3 Cefepime Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Cefepime Market Size Forecast by Type (2022-2027)
4.2.1 Global Cefepime Sales Forecast by Type (2022-2027)
4.2.2 Global Cefepime Revenue Forecast by Type (2022-2027)
4.2.3 Cefepime Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Cefepime Market Size by Application (2016-2021)
5.1.1 Global Cefepime Sales by Application (2016-2021)
5.1.2 Global Cefepime Revenue by Application (2016-2021)
5.1.3 Cefepime Price by Application (2016-2021)
5.2 Cefepime Market Size Forecast by Application (2022-2027)
5.2.1 Global Cefepime Sales Forecast by Application (2022-2027)
5.2.2 Global Cefepime Revenue Forecast by Application (2022-2027)
5.2.3 Global Cefepime Price Forecast by Application (2022-2027)

6 United States by Players, Type and Application
6.1 United States Cefepime Market Size YoY Growth 2016-2027
6.1.1 United States Cefepime Sales YoY Growth 2016-2027
6.1.2 United States Cefepime Revenue YoY Growth 2016-2027
6.1.3 United States Cefepime Market Share in Global Market 2016-2027
6.2 United States Cefepime Market Size by Players (International and Local Players)
6.2.1 United States Top Cefepime Players by Sales (2016-2021)
6.2.2 United States Top Cefepime Players by Revenue (2016-2021)
6.3 United States Cefepime Historic Market Review by Type (2016-2021)
6.3.1 United States Cefepime Sales Market Share by Type (2016-2021)
6.3.2 United States Cefepime Revenue Market Share by Type (2016-2021)
6.3.3 United States Cefepime Price by Type (2016-2021)
6.4 United States Cefepime Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Cefepime Sales Forecast by Type (2022-2027)
6.4.2 United States Cefepime Revenue Forecast by Type (2022-2027)
6.4.3 United States Cefepime Price Forecast by Type (2022-2027)
6.5 United States Cefepime Historic Market Review by Application (2016-2021)
6.5.1 United States Cefepime Sales Market Share by Application (2016-2021)
6.5.2 United States Cefepime Revenue Market Share by Application (2016-2021)
6.5.3 United States Cefepime Price by Application (2016-2021)
6.6 United States Cefepime Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Cefepime Sales Forecast by Application (2022-2027)
6.6.2 United States Cefepime Revenue Forecast by Application (2022-2027)
6.6.3 United States Cefepime Price Forecast by Application (2022-2027)

7 North America
7.1 North America Cefepime Market Size YoY Growth 2016-2027
7.2 North America Cefepime Market Facts & Figures by Country
7.2.1 North America Cefepime Sales by Country (2016-2021)
7.2.2 North America Cefepime Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Cefepime Market Size YoY Growth 2016-2027
8.2 Asia Pacific Cefepime Market Facts & Figures by Region
8.2.1 Asia Pacific Cefepime Sales by Region (2016-2021)
8.2.2 Asia Pacific Cefepime Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Cefepime Market Size YoY Growth 2016-2027
9.2 Europe Cefepime Market Facts & Figures by Country
9.2.1 Europe Cefepime Sales by Country (2016-2021)
9.2.2 Europe Cefepime Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Cefepime Market Size YoY Growth 2016-2027
10.2 Latin America Cefepime Market Facts & Figures by Country
10.2.1 Latin America Cefepime Sales by Country (2016-2021)
10.2.2 Latin America Cefepime Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Cefepime Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Cefepime Market Facts & Figures by Country
11.2.1 Middle East and Africa Cefepime Sales by Country (2016-2021)
11.2.2 Middle East and Africa Cefepime Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE

12 Company Profiles
12.1 Baxter
12.1.1 Baxter Corporation Information
12.1.2 Baxter Description and Business Overview
12.1.3 Baxter Cefepime Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Baxter Cefepime Products Offered
12.1.5 Baxter Recent Development
12.2 Apotex
12.2.1 Apotex Corporation Information
12.2.2 Apotex Description and Business Overview
12.2.3 Apotex Cefepime Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Apotex Cefepime Products Offered
12.2.5 Apotex Recent Development
12.3 B. Braun Medical
12.3.1 B. Braun Medical Corporation Information
12.3.2 B. Braun Medical Description and Business Overview
12.3.3 B. Braun Medical Cefepime Sales, Revenue and Gross Margin (2016-2021)
12.3.4 B. Braun Medical Cefepime Products Offered
12.3.5 B. Braun Medical Recent Development
12.4 Pfizer
12.4.1 Pfizer Corporation Information
12.4.2 Pfizer Description and Business Overview
12.4.3 Pfizer Cefepime Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Pfizer Cefepime Products Offered
12.4.5 Pfizer Recent Development
12.5 Perrigo
12.5.1 Perrigo Corporation Information
12.5.2 Perrigo Description and Business Overview
12.5.3 Perrigo Cefepime Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Perrigo Cefepime Products Offered
12.5.5 Perrigo Recent Development
12.6 Fresenius Kabi
12.6.1 Fresenius Kabi Corporation Information
12.6.2 Fresenius Kabi Description and Business Overview
12.6.3 Fresenius Kabi Cefepime Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Fresenius Kabi Cefepime Products Offered
12.6.5 Fresenius Kabi Recent Development
12.7 Sandoz (Novartis)
12.7.1 Sandoz (Novartis) Corporation Information
12.7.2 Sandoz (Novartis) Description and Business Overview
12.7.3 Sandoz (Novartis) Cefepime Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Sandoz (Novartis) Cefepime Products Offered
12.7.5 Sandoz (Novartis) Recent Development
12.8 Piramal Critical Care
12.8.1 Piramal Critical Care Corporation Information
12.8.2 Piramal Critical Care Description and Business Overview
12.8.3 Piramal Critical Care Cefepime Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Piramal Critical Care Cefepime Products Offered
12.8.5 Piramal Critical Care Recent Development
12.9 Meitheal Pharmaceuticals
12.9.1 Meitheal Pharmaceuticals Corporation Information
12.9.2 Meitheal Pharmaceuticals Description and Business Overview
12.9.3 Meitheal Pharmaceuticals Cefepime Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Meitheal Pharmaceuticals Cefepime Products Offered
12.9.5 Meitheal Pharmaceuticals Recent Development
12.10 BMS
12.10.1 BMS Corporation Information
12.10.2 BMS Description and Business Overview
12.10.3 BMS Cefepime Sales, Revenue and Gross Margin (2016-2021)
12.10.4 BMS Cefepime Products Offered
12.10.5 BMS Recent Development
12.11 Baxter
12.11.1 Baxter Corporation Information
12.11.2 Baxter Description and Business Overview
12.11.3 Baxter Cefepime Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Baxter Cefepime Products Offered
12.11.5 Baxter Recent Development
12.12 Sinopharm
12.12.1 Sinopharm Corporation Information
12.12.2 Sinopharm Description and Business Overview
12.12.3 Sinopharm Cefepime Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Sinopharm Products Offered
12.12.5 Sinopharm Recent Development
12.13 Shanghai Xinfeng Pharmaceutical
12.13.1 Shanghai Xinfeng Pharmaceutical Corporation Information
12.13.2 Shanghai Xinfeng Pharmaceutical Description and Business Overview
12.13.3 Shanghai Xinfeng Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Shanghai Xinfeng Pharmaceutical Products Offered
12.13.5 Shanghai Xinfeng Pharmaceutical Recent Development
12.14 Hebei Huamin Pharmaceutical
12.14.1 Hebei Huamin Pharmaceutical Corporation Information
12.14.2 Hebei Huamin Pharmaceutical Description and Business Overview
12.14.3 Hebei Huamin Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Hebei Huamin Pharmaceutical Products Offered
12.14.5 Hebei Huamin Pharmaceutical Recent Development
12.15 Nanjing Haichen Pharmaceutical
12.15.1 Nanjing Haichen Pharmaceutical Corporation Information
12.15.2 Nanjing Haichen Pharmaceutical Description and Business Overview
12.15.3 Nanjing Haichen Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Nanjing Haichen Pharmaceutical Products Offered
12.15.5 Nanjing Haichen Pharmaceutical Recent Development
12.16 Shandong Luoxin Pharmaceutical Group
12.16.1 Shandong Luoxin Pharmaceutical Group Corporation Information
12.16.2 Shandong Luoxin Pharmaceutical Group Description and Business Overview
12.16.3 Shandong Luoxin Pharmaceutical Group Cefepime Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Shandong Luoxin Pharmaceutical Group Products Offered
12.16.5 Shandong Luoxin Pharmaceutical Group Recent Development
12.17 Guangzhou Baiyunshan Tianxin Pharmaceutical
12.17.1 Guangzhou Baiyunshan Tianxin Pharmaceutical Corporation Information
12.17.2 Guangzhou Baiyunshan Tianxin Pharmaceutical Description and Business Overview
12.17.3 Guangzhou Baiyunshan Tianxin Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Products Offered
12.17.5 Guangzhou Baiyunshan Tianxin Pharmaceutical Recent Development
12.18 Yuekang Pharmaceutical Group
12.18.1 Yuekang Pharmaceutical Group Corporation Information
12.18.2 Yuekang Pharmaceutical Group Description and Business Overview
12.18.3 Yuekang Pharmaceutical Group Cefepime Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Yuekang Pharmaceutical Group Products Offered
12.18.5 Yuekang Pharmaceutical Group Recent Development
12.19 Chengdu Beite Pharmaceutical
12.19.1 Chengdu Beite Pharmaceutical Corporation Information
12.19.2 Chengdu Beite Pharmaceutical Description and Business Overview
12.19.3 Chengdu Beite Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Chengdu Beite Pharmaceutical Products Offered
12.19.5 Chengdu Beite Pharmaceutical Recent Development
12.20 Jiangsu Hengrui Pharmaceutical
12.20.1 Jiangsu Hengrui Pharmaceutical Corporation Information
12.20.2 Jiangsu Hengrui Pharmaceutical Description and Business Overview
12.20.3 Jiangsu Hengrui Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Jiangsu Hengrui Pharmaceutical Products Offered
12.20.5 Jiangsu Hengrui Pharmaceutical Recent Development
12.21 Hainan Star Pharmaceutical
12.21.1 Hainan Star Pharmaceutical Corporation Information
12.21.2 Hainan Star Pharmaceutical Description and Business Overview
12.21.3 Hainan Star Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2016-2021)
12.21.4 Hainan Star Pharmaceutical Products Offered
12.21.5 Hainan Star Pharmaceutical Recent Development
12.22 Hainan Hailing Pharmaceutical
12.22.1 Hainan Hailing Pharmaceutical Corporation Information
12.22.2 Hainan Hailing Pharmaceutical Description and Business Overview
12.22.3 Hainan Hailing Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2016-2021)
12.22.4 Hainan Hailing Pharmaceutical Products Offered
12.22.5 Hainan Hailing Pharmaceutical Recent Development
12.23 Shenzhen Xinlitai Pharmaceutical
12.23.1 Shenzhen Xinlitai Pharmaceutical Corporation Information
12.23.2 Shenzhen Xinlitai Pharmaceutical Description and Business Overview
12.23.3 Shenzhen Xinlitai Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2016-2021)
12.23.4 Shenzhen Xinlitai Pharmaceutical Products Offered
12.23.5 Shenzhen Xinlitai Pharmaceutical Recent Development
12.24 Shenzhen Lijian Pharmaceutical
12.24.1 Shenzhen Lijian Pharmaceutical Corporation Information
12.24.2 Shenzhen Lijian Pharmaceutical Description and Business Overview
12.24.3 Shenzhen Lijian Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2016-2021)
12.24.4 Shenzhen Lijian Pharmaceutical Products Offered
12.24.5 Shenzhen Lijian Pharmaceutical Recent Development
12.25 Suzhou Dongrui Pharmaceutical
12.25.1 Suzhou Dongrui Pharmaceutical Corporation Information
12.25.2 Suzhou Dongrui Pharmaceutical Description and Business Overview
12.25.3 Suzhou Dongrui Pharmaceutical Cefepime Sales, Revenue and Gross Margin (2016-2021)
12.25.4 Suzhou Dongrui Pharmaceutical Products Offered
12.25.5 Suzhou Dongrui Pharmaceutical Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Cefepime Industry Trends
13.2 Cefepime Market Drivers
13.3 Cefepime Market Challenges
13.4 Cefepime Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Cefepime Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer